Get the Stockscreener App
1.41
0.00%
0.00
Ryman Healthcare Stock (RHCGF) Forecast
The Ryman Healthcare (RHCGF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.31, representing a +630.94% increase from the current price of $1.41. The highest analyst price target is $10.38, and the lowest is $10.24.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RHCGF Price Target
Average 11.39
(+707.76% Upside)
Long-term RHCGF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ryman Healthcare financial reports and earnings history, Ryman Healthcare (RHCGF) stock could reach $20.99 by 2030, $43.10 by 2040 and $66.27 by 2050. See the projected annual prices until 2050 of the Ryman Healthcare stock below:
- Ryman Healthcare (RHCGF) is expected to reach an average price of $31.84 in 2035, with a high prediction of $32.26 and a low estimate of $31.55. This indicates an $2,158% rise from the last recorded price of $1.41.
- Ryman Healthcare (RHCGF) stock is projected to chart a bullish course in 2040, with an average price target of $43.10, representing an $2,956% surge from its current level. The forecast ranges from a conservative $42.52 to a sky-high $43.10.
- Our analysts predict Ryman Healthcare (RHCGF) to jump 3,801% by 2045, soaring from $53.49 to an average price of $55.00, potentially reaching $55.00. While $53.49 is the low estimate, the potential upside is significant.
- Ryman Healthcare (RHCGF) stock is expected to climb by 2050, reaching an average of $65.65, a $4,556% jump from its current level. However, a wide range of estimates exists, with high and low targets of $66.27 and $65.04, respectively, highlighting the market's uncertainty.
Ryman Healthcare Stock (RHCGF) Year by Year Forecast
Ryman Healthcare Stock (RHCGF) Price Forecast for 2025
Ryman Healthcare Stock (RHCGF) is expected to reach an average price of $10.53 in 2025, with a high prediction of $11.68 and a low estimate of $9.3806. This indicates an +646.70% rise from the last recorded price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $10.24 | $10.24 | $10.38 | +626.21% |
| June, 2025 | $10.55 | $10.45 | $10.59 | +648.06% |
| July, 2025 | $10.66 | $10.45 | $10.81 | +655.89% |
| August, 2025 | $10.87 | $10.67 | $11.03 | +670.85% |
| September, 2025 | $11.06 | $10.88 | $11.24 | +684.64% |
| October, 2025 | $11.27 | $11.08 | $11.46 | +699.28% |
| November, 2025 | $11.68 | $11.29 | $11.68 | +728.11% |
| December, 2025 | $11.53 | $11.50 | $11.61 | +717.59% |
Ryman Healthcare Stock (RHCGF) Price Forecast for 2026
The predicted value for Ryman Healthcare (RHCGF) in 2026 is set at an average of $12.89. Estimates vary from a peak of $14.06 to a trough of $11.71, indicating an +813.91% surge from the present price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.74 | $11.71 | $11.89 | +732.82% |
| February, 2026 | $12.04 | $11.92 | $12.11 | +753.74% |
| March, 2026 | $12.14 | $11.96 | $12.33 | +760.64% |
| April, 2026 | $12.36 | $12.17 | $12.54 | +776.42% |
| May, 2026 | $12.55 | $12.35 | $12.76 | +790.26% |
| June, 2026 | $12.98 | $12.56 | $12.98 | +820.29% |
| July, 2026 | $13.19 | $12.77 | $13.19 | +835.65% |
| August, 2026 | $13.03 | $12.98 | $13.10 | +824.21% |
| September, 2026 | $13.31 | $13.19 | $13.41 | +844.33% |
| October, 2026 | $13.53 | $13.25 | $13.63 | +859.42% |
| November, 2026 | $13.61 | $13.46 | $13.84 | +865.39% |
| December, 2026 | $13.87 | $13.68 | $14.06 | +883.50% |
Ryman Healthcare Stock (RHCGF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ryman Healthcare (RHCGF) is $15.02, with a high forecast of $16.23 and a low forecast of $13.82. This indicates an +965.55% increase from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.05 | $13.82 | $14.28 | +896.41% |
| February, 2027 | $14.49 | $14.03 | $14.49 | +927.83% |
| March, 2027 | $14.32 | $14.25 | $14.38 | +915.59% |
| April, 2027 | $14.53 | $14.46 | $14.71 | +930.82% |
| May, 2027 | $14.81 | $14.67 | $14.93 | +950.01% |
| June, 2027 | $14.88 | $14.75 | $15.14 | +955.18% |
| July, 2027 | $15.09 | $14.96 | $15.36 | +970.14% |
| August, 2027 | $15.38 | $15.18 | $15.58 | +990.58% |
| September, 2027 | $15.79 | $15.30 | $15.79 | +1,020% |
| October, 2027 | $16.01 | $15.51 | $16.01 | +1,035% |
| November, 2027 | $15.82 | $15.72 | $15.87 | +1,022% |
| December, 2027 | $16.04 | $15.93 | $16.23 | +1,037% |
Ryman Healthcare Stock (RHCGF) Price Forecast for 2028
In 2028, Ryman Healthcare (RHCGF) is projected to reach an average price of $17.38, with a high projection of $18.61 and a low estimate of $16.14. This indicates an +1,132% rise from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.30 | $16.14 | $16.44 | +1,056% |
| February, 2028 | $16.36 | $16.25 | $16.66 | +1,060% |
| March, 2028 | $16.57 | $16.47 | $16.88 | +1,075% |
| April, 2028 | $16.89 | $16.68 | $17.09 | +1,098% |
| May, 2028 | $17.31 | $16.78 | $17.31 | +1,128% |
| June, 2028 | $17.53 | $16.99 | $17.53 | +1,143% |
| July, 2028 | $17.33 | $17.20 | $17.36 | +1,129% |
| August, 2028 | $17.57 | $17.41 | $17.74 | +1,146% |
| September, 2028 | $17.79 | $17.54 | $17.96 | +1,161% |
| October, 2028 | $17.83 | $17.76 | $18.18 | +1,165% |
| November, 2028 | $18.18 | $17.97 | $18.39 | +1,189% |
| December, 2028 | $18.33 | $18.04 | $18.61 | +1,200% |
Ryman Healthcare Stock (RHCGF) Price Forecast for 2029
The 2029 price forecast for Ryman Healthcare Stock (RHCGF) is $19.51 on average, with a high prediction of $20.77 and a low estimate of $18.25. This represents an +1,284% increase from the previous price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $18.82 | $18.25 | $18.82 | +1,235% |
| February, 2029 | $18.61 | $18.47 | $18.64 | +1,220% |
| March, 2029 | $18.83 | $18.68 | $19.04 | +1,235% |
| April, 2029 | $19.06 | $18.89 | $19.26 | +1,252% |
| May, 2029 | $19.10 | $19.04 | $19.47 | +1,254% |
| June, 2029 | $19.31 | $19.26 | $19.69 | +1,269% |
| July, 2029 | $19.69 | $19.47 | $19.91 | +1,297% |
| August, 2029 | $19.82 | $19.52 | $20.12 | +1,306% |
| September, 2029 | $20.34 | $19.73 | $20.34 | +1,343% |
| October, 2029 | $20.12 | $19.94 | $20.13 | +1,327% |
| November, 2029 | $20.33 | $20.15 | $20.56 | +1,342% |
| December, 2029 | $20.55 | $20.36 | $20.77 | +1,358% |
Ryman Healthcare Stock (RHCGF) Price Forecast for 2030
Ryman Healthcare Stock (RHCGF) is expected to reach an average price of $21.85 in 2030, with a high forecast of $23.16 and a low forecast of $20.55. This signifies an +1,450% surge from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.57 | $20.55 | $20.99 | +1,359% |
| February, 2030 | $20.99 | $20.76 | $21.21 | +1,388% |
| March, 2030 | $21.11 | $20.79 | $21.42 | +1,397% |
| April, 2030 | $21.64 | $21.00 | $21.64 | +1,435% |
| May, 2030 | $21.86 | $21.21 | $21.86 | +1,450% |
| June, 2030 | $21.62 | $21.42 | $21.62 | +1,433% |
| July, 2030 | $21.83 | $21.63 | $22.07 | +1,448% |
| August, 2030 | $22.04 | $21.84 | $22.29 | +1,463% |
| September, 2030 | $22.05 | $22.05 | $22.51 | +1,464% |
| October, 2030 | $22.49 | $22.26 | $22.72 | +1,495% |
| November, 2030 | $22.60 | $22.26 | $22.94 | +1,503% |
| December, 2030 | $23.16 | $22.47 | $23.16 | +1,542% |
6.25%
0.05%
Cap:
|
Volume (24h):